| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |